References
- Howard G., Wagenknecht L. E., Burke G. L., Diez‐Roux A., Evans G. W., McGovern P., et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Med Assoc 1998; 279: 119–24
- O'Callaghan P. A., Fitzgerald A., Fogarty J., Gaffney P., Hanbidge M., Boran G., et al. New and old cardiovascular risk factors: C‐reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. Eur J Cardiovasc Prev Rehabil 2005; 12: 542–7
- Bazzano L. A., He J., Muntner P., Vupputuri S., Whelton P. K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003; 138: 891–7
- Winniford M. D., Wheelan K. R., Kremers M. S., Ugolini V., van den Berg E Jr., Niggemann E. H., et al. Smoking‐induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986; 73: 662–7
- Glass C. K., Witztum J. L. Atherosclerosis: the road ahead. Cell 2001; 104: 503–16
- Bermudez E. A., Rifai N., Buring J. E., Manson J. E., Ridker P. M. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002; 89: 1117–19
- Willett W. C., Green A., Stampfer M. J., Speizer F. E., Colditz G. A., Rosner B., et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303–9
- Dobson A. J., Alexander H. M., Heller R. F., Lloyd D. M. How soon after quitting smoking does risk of heart attack decline?. J Clin Epidemiol 1991; 44: 1247–53
- Lee K. W., Lip G. Y. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163: 2368–92
- Aukrust P., Bjornsen S., Lunden B., Otterdal K., Ng E. C., Ameln W., et al. Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy. Thromb Haemost 2000; 84: 183–7
- Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191–203
- Blankenberg S., Rupprecht H. J., Bickel C., Peetz D., Hafner G., Tiret L., et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336–42
- Ridker P. M., Hennekens C. H., Roitman‐Johnson B., Stampfer M. J., Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88–92
- Tonstad S., Sundfor T., Seljeflot I. Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease. Am J Cardiol 2005; 95: 1187–91
- Scott D. A., Stapleton J. A., Wilson R. F., Sutherland G., Palmer R. M., Coward P. Y., et al. Dramatic decline in circulating intercellular adhesion molecule‐1 concentration on quitting tobacco smoking. Blood Cells Mol Dis 2000; 26: 255–8
- Palmer R. M., Stapleton J. A., Sutherland G., Coward P. Y., Wilson R. F., Scott D. A. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM‐1, sCD44v5, sCD44v6). Eur J Clin Invest 2002; 32: 852–7
- Perlstein T. S., Lee R. T. Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol 2006; 26: 250–6
- Celec P. Nuclear factor kappa B‐molecular biomedicine: the next generation. Biomed Pharmaco 2004; 58: 365–71
- Hoffmann E., Dittrich‐Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin‐8 gene expression. J Leuk Biol 2002; 72: 847–55
- Holtmann H., Winzen R., Holland P., Eickemeier S., Hoffmann E., Wallach D., et al. Induction of interleukin‐8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine‐ or stress‐activated signal transduction pathways. Mol Cell Biol 1999; 19: 6742–53
- Ohsawa M., Okayama A., Nakamura M., Onoda T., Kato K., Itai K., et al. CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long‐term smoking cessation in male smokers. Prev Med 2005; 41: 651–6